Ramya Surapaneni
Ramya Surapaneni is an accomplished professional currently serving as the Director of Safety & Pharmacovigilance at Precigen, a pioneering biotechnology company focusing on gene and cell therapy. With extensive experience in pharmacovigilance, she has a proven track record in ensuring the safety and efficacy of therapeutics across various stages of development. In her current role, Ramya oversees safety assessments, adverse event reporting, and regulatory compliance, ensuring that Precigen's innovative therapies adhere to global safety standards.
Her career is marked by her ability to lead cross-functional teams and collaborate with regulatory bodies, ensuring that safety monitoring is integrated seamlessly into both preclinical and clinical development processes. Ramya's expertise extends to risk management, safety signal detection, and implementing strategies to mitigate potential safety concerns. This makes her a pivotal figure in ensuring that drug safety is maintained, from discovery through to post-market surveillance.
With a solid foundation in biotechnology and pharmacovigilance, Ramya is passionate about advancing therapies that improve patient outcomes while maintaining the highest standards of safety. She is recognized for her leadership, strategic thinking, and her commitment to patient safety in the rapidly evolving biotech space.